KI1001

DRUG2 trials

Sponsors

Kuhnil Pharmaceutical Co., Ltd.

Conditions

Sleep Initiation and Maintenance Disorders

Phase 3

Efficacy and Safety of KI1001 in ≥ 55 Years Old Insomnia Patients

CompletedNCT01450228

Kuhnil Pharmaceutical Co., Ltd.Sleep Initiation and Maintenance Disorders

Start: 2011-03-31End: 2012-03-31Updated: 2012-04-24

Efficacy and Safety of KI1001 in the Treatment of ≥ 55 Years Old Insomnia Patients

CompletedNCT02087722

Kuhnil Pharmaceutical Co., Ltd.Sleep Initiation and Maintenance Disorders

Start: 2013-08-31End: 2014-01-31Updated: 2014-03-14